Suppresses: in vivo and in vitro, IL-1ß, IL-6, IL-13, NF-kB, CXCL8, GM-CSF, I-CAM, reduced atopic dermatitis-like symptoms [395]Enhances: skin barrier protein, involucrin increased in murine skin [395]. Here, NFKB1 is linked to atopic eczema.